Status:

ACTIVE_NOT_RECRUITING

Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers

Lead Sponsor:

Ankara Etlik City Hospital

Conditions:

Gastrointestinal Cancers

Frailty

Eligibility:

All Genders

65+ years

Brief Summary

This study evaluates the effectiveness of the G8 and VES-13 frailty scales in predicting chemotherapy-related toxicity in older patients with gastrointestinal cancers receiving adjuvant chemotherapy. ...

Detailed Description

Background Gastrointestinal (GI) cancers in older adults are often accompanied by frailty, malnutrition, and functional decline, which increase the risk of chemotherapy-related toxicity. While chemot...

Eligibility Criteria

Inclusion

  • Age ≥65 years
  • Histologically confirmed non-metastatic or locally advanced gastrointestinal cancers (esophageal, gastric, colorectal, pancreatic, biliary tract)
  • Planned to receive adjuvant chemotherapy (standard regimens such as FOLFOX, CAPEOX, FOLFIRI, FOLFOXIRI, FOLFIRINOX, capecitabine, gemcitabine, 5-FU/leucovorin, or oxaliplatin-based regimens)
  • ECOG Performance Status 0-2
  • Ability to complete frailty and functional assessment questionnaires (G8, VES-13, SARC-F, MNA-SF, Katz ADL, Lawton-Brody IADL)
  • Signed informed consent

Exclusion

  • ECOG Performance Status ≥3
  • Patients planned for neoadjuvant chemotherapy or chemoradiotherapy
  • Prior systemic chemotherapy or radiotherapy for the same cancer diagnosis
  • Severe cognitive impairment preventing questionnaire completion
  • Patients with advanced frailty at baseline screening
  • Concurrent enrollment in another interventional clinical trial

Key Trial Info

Start Date :

January 15 2024

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2026

Estimated Enrollment :

72 Patients enrolled

Trial Details

Trial ID

NCT07184047

Start Date

January 15 2024

End Date

January 1 2026

Last Update

September 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Etlik City Hospital, Medical Oncology Department

Ankara, Yenimahalle, Turkey (Türkiye), 06210